Tech Company Financing Transactions
Secura Bio Funding Round
Athyrium Opportunities Fund and private investors invested in a $145 million capital raise for Secura Bio. The funding round closed on 3/7/2019.
Transaction Overview
Company Name
Announced On
3/7/2019
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$145,000,000
Round
Undisclosed
Investors
Athyrium Opportunities Fund (Lead Investor) (Jeffrey Ferrell)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1887 Whitney Mesa Dr. 1050
Henderson, NV 89014
USA
Henderson, NV 89014
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
For Secura Bio, a diagnosis of a serious illness can change life in an instant and finding treatment options is key. At Secura Bio they see things differently. they develop and commercialize innovative medicines and life changing products for the patients that need them most.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joseph Limber
Chief Financial Officer
Mark Spring
VP - Bus. Development
Juan Estruch
VP - General Counsel
Brett Lund
VP - Operations
William Davis
Browse more venture capital transactions:
Prev: 3/7/2019: Tasso venture capital transaction
Next: 3/7/2019: OpenMartech venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records on this site come from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs